Dr. Pendleton Wickersham, M.D.
What this data tells you about Dr. Wickersham
Dr. Pendleton Wickersham is a rheumatology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Wickersham performed 166,354 Medicare services across 6,584 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wickersham received a total of $1,008,564 from 55 pharmaceutical and/or device companies across 2326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wickersham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 57,827 | $5 | $8 |
| Injection, anifrolumab-fnia, 1 mg | 44,742 | $13 | $32 |
| Certolizumab injection (Cimzia) | 37,200 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 7,923 | $18 | $29 |
| Injection, rituximab, 10 mg | 2,410 | $63 | $131 |
| Office visit, established patient (30-39 min) | 2,150 | $90 | $210 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 1,536 | $17 | $49 |
| Blood draw (venipuncture) | 1,246 | $6 | $6 |
| Complete blood count (CBC) with differential | 1,032 | $7 | $21 |
| Comprehensive metabolic blood panel | 1,024 | $10 | $29 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 984 | $13 | $60 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 953 | $4 | $10 |
| C-reactive protein test (inflammation marker) | 943 | $5 | $14 |
| Drug screening test | 667 | $60 | $122 |
| Vitamin D level test | 540 | $28 | $74 |
| Administration of chemotherapy into vein, 1 hour or less | 510 | $98 | $246 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 341 | $56 | $136 |
| Measurement of complement (immune system proteins), antigen, | 322 | $12 | $33 |
| Analysis of substance using immunoassay technique, multiple step method | 280 | $11 | $40 |
| Manual urinalysis test with examination using microscope, non-automated | 270 | $4 | $9 |
| Injection of additional new drug or substance into vein | 255 | $12 | $42 |
| Screening test for autoimmune disorder | 216 | $12 | $33 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 213 | $81 | $181 |
| Injection, methylprednisolone acetate, 80 mg | 212 | $9 | $26 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 209 | $3 | $9 |
| Measurement of dna antibody, native or double stranded | 191 | $13 | $38 |
| Administration of chemotherapy into vein, each additional hour | 153 | $21 | $52 |
| Drug injection, under skin or into muscle | 147 | $10 | $30 |
| Rheumatoid factor level | 140 | $6 | $16 |
| Measurement of antibody for assessment of autoimmune disorder, titer | 127 | $11 | $28 |
| X-ray of hand, 2 views | 125 | $23 | $53 |
| Tuberculosis test, gamma interferon | 123 | $60 | $153 |
| Injection, diphenhydramine hcl, up to 50 mg | 121 | $1 | $20 |
| Flu vaccine administration | 109 | $30 | $40 |
| Bone density scan (DEXA) | 98 | $36 | $92 |
| Flu vaccine, quadrivalent | 91 | $76 | $100 |
| Measurement of antibody for rheumatoid arthritis assessment | 90 | $13 | $36 |
| Thyroid stimulating hormone (TSH) test | 88 | $16 | $46 |
| New patient office visit (45-59 min) | 80 | $115 | $313 |
| Thyroxine (thyroid chemical), total | 77 | $6 | $19 |
| Thyroid hormone evaluation | 76 | $6 | $18 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 51 | $100 | $314 |
| Office visit, established patient (20-29 min) | 46 | $53 | $142 |
| X-ray of knee, 1-2 views | 40 | $22 | $54 |
| Cyanocobalamin (vitamin b-12) level, unsaturated binding capacity | 38 | $14 | $20 |
| Creatine kinase (cardiac enzyme) level, total | 36 | $6 | $18 |
| Lipid panel (cholesterol and triglycerides) | 34 | $13 | $22 |
| Parathyroid hormone level test | 34 | $40 | $113 |
| Liver function blood test panel | 29 | $8 | $22 |
| Uric acid level test | 28 | $4 | $12 |
| Injection of trigger points, 3 or more muscles | 26 | $42 | $122 |
| X-ray of foot, 2 views | 22 | $20 | $47 |
| Calcium level, total | 22 | $5 | $12 |
| Blood creatinine level | 22 | $5 | $12 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 18 | $20 | $36 |
| X-ray of lower and sacral spine, minimum of 4 views | 15 | $37 | $94 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 14 | $25 | $63 |
| Cardiolipin antibody (tissue antibody) measurement | 14 | $25 | $63 |
| Microsomal antibodies (autoantibody) measurement | 12 | $14 | $36 |
| Thyroglobulin (thyroid protein) antibody measurement | 12 | $16 | $39 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for rheumatology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wickersham is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wickersham experienced with tocilizumab injection (actemra)?
Does Dr. Wickersham receive payments from pharmaceutical companies?
How do Dr. Wickersham's costs compare to other rheumatologys in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology